IGF2BP1 and hepatocellular carcinoma: Collectively, these results demonstrate that PTPN13 downregulation induced by HBx-induced promoter methylation inhibits HCC proliferation by decreasing c-Myc mRNA stability in an IGF2BP1-dependent manner (Fig. 8F).